Concepedia

Author

Melissa Alsina

Moffitt Cancer CenterORCID

Also Known As

Barlogie, Bart, M Alsina, M Mercé Alsina, M. Alsina, M. M. Alsina, Melissa Alsina, Rafat Abonour

538

Publications

17.9K

Citations

64

H-Index

81

Concepts

All Affiliations

Moffitt Cancer CenterDana-Farber Cancer InstituteThe University of Texas MD Anderson Cancer CenterHackensack University Medical CenterEmory University
MA

About

Melissa Alsina is an author at Moffitt Cancer Center specializing in medicine, hematology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

25

40

2.9K

2

Health Sciences

16

22

1.3K

3

Blood Transplantation

4

4

191

4

Public Health

2

2

125

5

Business

1

1

18

Melissa Alsina

×

153

Publications

16.1K

Citations

62

H-Index

YearCitations

A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma

Paul G. Richardson, Bart Barlogie, James R. Berenson,

New England Journal of Medicine

2003

2.6K

A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma

Sundar Jagannath, Bart Barlogie, James R. Berenson,

British Journal of Haematology

2004

739

A phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myeloma

David S. Siegel, Thomas G. Martin, Michael Wang,

Blood

2012

654

Frequency, Characteristics, and Reversibility of Peripheral Neuropathy During Treatment of Advanced Multiple Myeloma With Bortezomib

Paul G. Richardson, Hannah Briemberg, Sundar Jagannath,

Journal of Clinical Oncology

2006

644

A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma

Paul G. Richardson, Emily Blood, Constantine S. Mitsiades,

Blood

2006

520

Extended follow-up of a phase 3 trial in relapsed multiple myeloma: final time-to-event results of the APEX trial

Paul G. Richardson, Pieter Sonneveld, Michael Schuster,

Blood

2007

509

Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma

Paul G. Richardson, Susanna Jacobus, Edie Weller,

New England Journal of Medicine

2022

428

Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma

Sun Jin Choi, José C. Cruz, Fiona E. Craig,

Blood

2000

395

Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study

Shaji Kumar, Meletios Α. Dimopoulos, Efstathios Kastritis,

Leukemia

2017

348

Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study

Nancy Gillis, Markus Ball, Qing Zhang,

The Lancet Oncology

2016

307

Page 1